EAU prostate cancer guidelines 2019: What changed and why?
Prof Nicolas Mottet - University Hospital St Etienne, St Etienne, France
EAU prostate cancer guidelines 2019: What changed and why? ( Prof Nicolas Mottet - University Hospital St Etienne, St Etienne, France )
8 May 2019
Neoadjuvant treatment before radical prostatectomy: Current situation
Prof Nicolas Mottet - University Hospital St Etienne, St Etienne, France
Neoadjuvant treatment before radical prostatectomy: Current situation ( Prof Nicolas Mottet - University Hospital St Etienne, St Etienne, France )
8 May 2019
First- and second-line treatments for locally advanced renal cell carcinoma
Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA
First- and second-line treatments for locally advanced renal cell carcinoma ( Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA )
8 May 2019
Emerging management of metastatic castration-sensitive prostate cancer: front-li...
Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA
Emerging management of metastatic castration-sensitive prostate cancer: front-line chemotherapy vs. oral therapy ( Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA )
8 May 2019
Highlights from IGILUC 2019
Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
Highlights from IGILUC 2019 ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )
8 May 2019
Quality of life and local treatment of oligometastatic prostate cancer
Prof Claude Abbou - Clinique de l'Alma, Paris, France
Quality of life and local treatment of oligometastatic prostate cancer ( Prof Claude Abbou - Clinique de l'Alma, Paris, France )
8 May 2019
Challenges in the treatment of upper urinary tract tumours
Prof Amr Emara - Basingstoke and North Hampshire Hospital, Basingstoke, UK
Challenges in the treatment of upper urinary tract tumours ( Prof Amr Emara - Basingstoke and North Hampshire Hospital, Basingstoke, UK )
8 May 2019
PARP inhibitors and their side effects in solid tumour therapy
Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA
PARP inhibitors and their side effects in solid tumour therapy ( Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA )
8 May 2019
Challenges to Jordanian Muslim men with prostate cancer
Abdulmalik Hasanain - Victoria University of Wellington, Wellington, New Zealand
Challenges to Jordanian Muslim men with prostate cancer ( Abdulmalik Hasanain - Victoria University of Wellington, Wellington, New Zealand )
8 May 2019
5' UTR mutations in prostate cancer
Dr Yiting Lim, Fred Hutchinson Cancer Research Center, Seattle, USA
5' UTR mutations in prostate cancer ( Dr Yiting Lim, Fred Hutchinson Cancer Research Center, Seattle, USA )
15 Apr 2019
Evaluation of M7824, a bifunctional fusion protein targeting TGF-β and PD-L1, in...
Dr James Gulley - National Cancer Institute, Bethesda, USA
Evaluation of M7824, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with HPV-associated malignancies ( Dr James Gulley - National Cancer Institute, Bethesda, USA )
15 Apr 2019
Risk factors for prostate cancer in men of African descent
Dr Faruk Mohammed - Ahmadu Bello University, Zaria, Nigeria
Risk factors for prostate cancer in men of African descent ( Dr Faruk Mohammed - Ahmadu Bello University, Zaria, Nigeria )
15 Apr 2019